(Q52552682)

3 May 2018

title

TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type. (English)

1 reference

3 May 2018

author name string

Rajyalakshmi Luthra

series ordinal

1

1 reference

3 May 2018

Beatriz Sanchez-Vega

series ordinal

2

1 reference

3 May 2018

L Jeffrey Medeiros

series ordinal

3

1 reference

3 May 2018

publication date

1 January 2004

1 reference

3 May 2018

published in

Modern Pathology

1 reference

3 May 2018

volume

17

1 reference

3 May 2018

issue

1

1 reference

3 May 2018

page(s)

96-103

1 reference

3 May 2018

describes a project that uses

capillary electrophoresis

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Real-Time t(14;18)(q32;q21) PCR assay combined with high-resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

7 January 2021

inferred from DOI database lookup

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

7 January 2021

inferred from DOI database lookup

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800026

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/MODPATHOL.3800026

1 reference

3 May 2018

1 reference

3 May 2018